• linkedin
  • Increase Font
  • Sharebar

    Best of AUA 2015: PCa surveillance, surgical controversies create buzz

    New Orleans—It’s been said that the best treatment for low-risk prostate cancer is no treatment at all. A number of studies at the 2015 AUA annual meeting appeared to bear that out, showing active surveillance to be a safe and increasingly common approach in this patient population.

    The meeting’s “Crossfire: Controversies in Urology” was a highlight for the second year in a row, with debates about whether shock wave lithotripsy should be retired and whether focal therapy for prostate cancer is hope or hype drawing big crowds.  

    Abstracts comparing surgical techniques, including robotic techniques, were hot, as were studies on new treatments for BPH, the use of mesh in pelvic organ prolapse, and the safety of testosterone replacement therapy.

    Urology Times’ “Best of AUA 2015” report provides a guide to the meeting’s take-home messages in 15 therapeutic areas—an information-packed, condensed summary of the top papers and presentations. The editors’ choices for high-interest messages are highlighted in boldface type.

    Click below to jump a disease state:

    Prostate Cancer

    Basic Science Research

    Infection/Inflammation

    Infertility/Andrology

    Stone Disease/Endourology

    Transplantation/Vascular Surgery

    Penile, Testis, and Urethral Cancer

    Trauma/Reconstruction/Diversion

    Sexual Function/Dysfunction

    Female Urology/Incontinence/Urodynamics

    BPH/LUTS

    Minimally Invasive Surgery (Laparoscopy/Robotics)

    Outcomes Analysis

    Kidney Cancer

    Bladder Cancer

    NEXT: Prostate Cancer

    Richard R. Kerr
    Kerr is group content director for Urology Times.
    Benjamin P. Saylor
    Saylor is content managing editor for Urology Times.
    Cheryl Guttman Krader
    Cheryl Guttman Krader is a contributor to Dermatology Times, Ophthalmology Times, and Urology Times.
    Wayne Kuznar
    Wayne Kuznar is a contributor to Urology Times.

    0 Comments

    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available

    Poll